{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:12:55Z","timestamp":1792800775287,"version":"4.5.0"},"reference-count":54,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T00:00:00Z","timestamp":1761523200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Spatially fractionated radiation therapy (SFRT) has demonstrated high clinical response rates with minimal toxicity in adult patients with bulky tumors, including radioresistant histologies. However, there is limited clinical data on SFRT in pediatric patients, and optimal techniques and dose regimens remain unclear. This study presents our single-institution experience with SFRT for the palliative treatment of bulky pediatric tumors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and materials<\/jats:title>\n                    <jats:p>A retrospective review was conducted on six pediatric patients with metastatic or unresectable bulky tumors treated with SFRT. SFRT was delivered using VMAT in the form of Lattice Radiation Therapy (LRT). SFRT fraction doses ranged from 10\u201315 Gy, with 7\u201326 high-dose vertices per treatment. Sequential conventional external beam radiation therapy was delivered in 6 courses (67%), and SFRT was used for re-irradiation in 3 courses (33%). A radiobiological modeling approach was employed to estimate treatment effects across varying cancer and normal cell radiosensitivity levels.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Six pediatric and young adult patients (median age: 10 years) received in total 9 SFRT courses. Tumor sites included the liver (4), abdomen (3), pelvis (1), and thorax (1), with a median gross tumor volume of 666 cc. Median follow-up was 1.7 months. Tumor volume reductions were observed in 67% of treated sites (mean reduction: 279.3 cc), with significant clinical improvements in symptoms (e.g., pain, gastrointestinal symptom relief) and no grade 3 or higher toxicities. Radiobiological modeling data indicates that SFRT improves the therapeutic ratio, particularly when cancer cells are radioresistant and surrounding normal tissues are radiosensitive. Increasing the number of high-dose cores may further enhance this ratio.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>SFRT seems to be a safe and effective palliative treatment for pediatric bulky tumor patients in our preliminary study. Radiobiologic modeling suggests that increasing the density of high-dose cores can enhance the therapeutic ratio, potentially reducing normal tissue toxicity.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2025.1648847","type":"journal-article","created":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:18:50Z","timestamp":1761542330000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Initial experience of spatially fractionated lattice radiation therapy for palliative treatment of pediatric bulky tumors"],"prefix":"10.3389","volume":"15","author":[{"given":"Hualin","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur","family":"Olch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye Ri","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brittney","family":"Chau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Lukas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric L.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,10,27]]},"reference":[{"key":"B1","article-title":"Chapter 1. Introduction to the principles of spatially fractionated radiotherapy","volume-title":"Book \u201cSpatially Fractionated, Microbeam and FLASH Radiation Therapy, A Physics and Multidisciplinary Approache\u201d","author":"Butterworth","year":"2023"},{"key":"B2","article-title":"Chapter 3. The immunologic effects of nonuniform dose irradiation","volume-title":"Book \u201cSpatially Fractionated, Microbeam and FLASH Radiation Therapy, A Physics and Multidisciplinary Approache","author":"Marciscano","year":"2023"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19900701)66:1<114::AID-CNCR2820660121>3.0.CO;2-L","article-title":"Palliative treatment of advanced cancer using multiple nonconfluent pencil beam radiation","volume":"66","author":"Mohiuddin","year":"1990","journal-title":"A pilot study. Cancer"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/S0360-3016(99)00170-4","article-title":"High-dose spatially-fractionated radiation (GRID): a new paradigm in the management of advanced cancers","volume":"45","author":"Mohiuddin","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctro.2019.10.004","article-title":"Spatially fractionated radiation therapy: History, present and the future","volume":"20","author":"Yan","year":"2020","journal-title":"Clin Transl Radiat Oncol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7759\/cureus.15","article-title":"Lattice radiotherapy with RapidArc for treatment of gynecological tumors: dosimetric and early clinical evaluations","volume":"2","author":"Amendola","year":"2010","journal-title":"Cureus"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.9","article-title":"On modern technical approaches of three-dimensional high-dose Lattice radiotherapy (LRT)","volume":"2","author":"Wu","year":"2010","journal-title":"Cureus"},{"key":"B8","doi-asserted-by":"publisher","first-page":"101308","DOI":"10.1016\/j.adro.2023.101308","article-title":"Practice patterns of spatially fractionated radiation therapy: A clinical practice survey","volume":"9","author":"Mayr","year":"2024","journal-title":"Adv Radiat Oncol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"100866","DOI":"10.1016\/j.adro.2021.100866","article-title":"An international consensus on the design of prospective clinical-translational trials in spatially fractionated radiation therapy","volume":"7","author":"Mayr","year":"2022","journal-title":"Adv Radiat Oncol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1520-6823(1996)4:1<41::AID-ROI7>3.0.CO;2-M","article-title":"Spatially fractionated (GRID) radiation for palliative treatment of advanced cancer","volume":"4","author":"Mohiuddin","year":"1996","journal-title":"Radiat Oncocogy Investigations"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2011.01.065","article-title":"High-dose spatially fractionated GRID radiation therapy (SFGRT): a comparison of treatment outcomes with Cerrobend vs. MLC SFGRT","volume":"82","author":"Neuner","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14163909","article-title":"Impressive results after \u201cMetabolism-guided\u201d Lattice irradiation in patients submitted to palliative radiation therapy: preliminary results of LATTICE_01 multicenter study","volume":"14","author":"Ferini","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B13","doi-asserted-by":"publisher","first-page":"101566","DOI":"10.1016\/j.adro.2024.101566","article-title":"Time-related outcome following palliative spatially fractionated stereotactic radiation therapy (Lattice) of large tumors - A case series","volume":"9","author":"Studer","year":"2024","journal-title":"Adv Radiat Oncol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"101665","DOI":"10.1016\/j.adro.2024.101665","article-title":"Spatially fractionated radiation therapy for palliation in patients with large cancers: A retrospective study","volume":"10","author":"Iori","year":"2025","journal-title":"Adv Radiat Oncol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"100830","DOI":"10.1016\/j.ctro.2024.100830","article-title":"Spatially fractionated radiotherapy (Lattice SFRT) in the palliative treatment of locally advanced bulky unresectable head and neck cancer","volume":"48","author":"Xu","year":"2024","journal-title":"Clin Transl Radiat Oncol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2009.03.030","article-title":"Evaluation of spatially fractionated radiotherapy (GRID) and definitive chemoradiotherapy with curative intent for locally advanced squamous cell carcinoma of the head and neck: initial response rates and toxicity","volume":"76","author":"Pe\u00f1agar\u00edcano","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B17","doi-asserted-by":"publisher","first-page":"101401","DOI":"10.1016\/j.adro.2023.101401","article-title":"Spatially fractionated radiation therapy in sarcomas: A large single-institution experience","volume":"9","author":"Ahmed","year":"2024","journal-title":"Adv Radiat Oncol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1667\/RADE-20-00100.1","article-title":"Spatially fractionated radiotherapy (GRID) prior to standard neoadjuvant conventionally fractionated radiotherapy for bulky, high-risk soft tissue and osteosarcomas: feasibility, safety, and promising pathologic response rates","volume":"194","author":"Snider","year":"2020","journal-title":"Radiat Res"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.phro.2022.04.010","article-title":"Physical aspects of a spatially fractionated radiotherapy technique for large soft tissue sarcomas","volume":"22","author":"Borzov","year":"2022","journal-title":"Phys Imaging Radiat Oncol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.ctro.2018.01.003","article-title":"Improved outcome of treating locally advanced lung cancer with the use of Lattice Radiotherapy (LRT): A case report","volume":"9","author":"Amendola","year":"2018","journal-title":"Clin Transl Radiat Oncol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1667\/RADE-20-00038.1","article-title":"Spatially fractionated radiation therapy using lattice radiation in far-advanced bulky cervical cancer: A clinical and molecular imaging and outcome study","volume":"194","author":"Amendola","year":"2020","journal-title":"Radiat Res"},{"key":"B22","article-title":"Lattice radiotherapy (LRT): case report of bulky cervical cancer (CC)","volume":"14","author":"Luis Larrea","year":"2022","journal-title":"Cureus"},{"key":"B23","doi-asserted-by":"publisher","first-page":"100569","DOI":"10.1016\/j.ctro.2022.100569","article-title":"Lattice Radiation Therapy in clinical practice: A systematic review","volume":"39","author":"Iori","year":"2023","journal-title":"Clin Transl Radiat Oncol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1177\/153303460600500608","article-title":"Spatially fractionated GRID radiation treatment of advanced neck disease associated with head and neck cancer","volume":"5","author":"Huhn","year":"2006","journal-title":"Technol Cancer Res Treat"},{"key":"B25","article-title":"Chapter 16. SFRT dose prescription","volume-title":"Book \u201cSpatially fractionated, microbeam and FLASH radiation therapy, A Physics and Multidisciplinary Approache\u201d","author":"Mayr","year":"2023"},{"key":"B26","unstructured":"SFRT Clinical Trials\n          \n          \n          Bristol, United Kingdom\n          National Center for Biotechnology Information\n          \n          2023"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1667\/RADE-20-00066.1","article-title":"The technical and clinical implementation of LATTICE radiation therapy (LRT)","volume":"194","author":"Wu","year":"2020","journal-title":"Radiat Res"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1667\/RADE-20-00047.1","article-title":"Photon GRID radiation therapy: A physics and dosimetry white paper from the radiosurgery society (RSS) GRID\/LATTICE, microbeam and FLASH radiotherapy working group","volume":"194","author":"Zhang","year":"2020","journal-title":"Radiat Res"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2006.08.059","article-title":"Dosimetric validation of the MCNPX Monte Carlo simulation for radiobiologic studies of megavoltage grid radiotherapy","volume":"66","author":"Zhang","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2007.08.024","article-title":"Fractionated grid therapy in treating cervical cancers: conventional fractionation or hypofractionation","volume":"70","author":"Zhang","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B31","doi-asserted-by":"publisher","first-page":"021727","DOI":"10.1118\/1.4862837","article-title":"Impact of dose size in single fraction spatially fractionated (grid) radiotherapy for melanoma","volume":"41","author":"Zhang","year":"2014","journal-title":"Med Phys"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14041037","article-title":"A dosimetric parameter reference look-up table for GRID collimator-based spatially fractionated radiation therapy","volume":"14","author":"Zhang","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1080\/095530097143149","article-title":"The link between low-LET dose-response relations and the underlying kinetics of damage production\/repair\/misrepair","volume":"72","author":"Sachs","year":"1997","journal-title":"Int J Radiat Biol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.semradonc.2024.05.004","article-title":"Bystander effects in spatially fractionated radiation therapy: from molecule to organism to clinical implications","volume":"34","author":"Jenkins","year":"2024","journal-title":"Semin Radiat Oncol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmp.2007.09.001","article-title":"On the parameter describing the generalised equivalent uniform dose (gEUD) for tumours","volume":"23","author":"S\u00f8vik","year":"2007","journal-title":"Phys Med"},{"key":"B36","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s13014-024-02514-6","article-title":"Spatially fractionated GRID radiation potentiates immune-mediated tumor control","volume":"19","author":"Bekker","year":"2024","journal-title":"Radiat Oncol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"20160485","DOI":"10.1259\/bjr.20160485","article-title":"Modelling responses to spatially fractionated radiation fields using preclinical image-guided radiotherapy","volume":"90","author":"Butterworth","year":"2017","journal-title":"Br J Radiol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1088\/1361-6560\/ac3119","article-title":"Investigating spatial fractionation and radiation induced bystander effects: a mathematical modelling approach","volume":"66","author":"Cahoon","year":"2021","journal-title":"Phys Med Biol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3390\/jpm14040436","article-title":"Computational approach for spatially fractionated radiation therapy (SFRT) and immunological response in precision radiation therapy","volume":"14","author":"Castorina","year":"2024","journal-title":"J Pers Med"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1088\/1361-6560\/ace819","article-title":"Radio-immune response modelling for spatially fractionated radiotherapy","volume":"68","author":"Cho","year":"2023","journal-title":"Phys Med Biol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2023.08.061","article-title":"Dosimetric validation for prospective clinical trial of GRID collimator-based spatially fractionated radiation therapy: dose metrics consistency and heterogeneous pattern reproducibility","volume":"118","author":"Zhang","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14174267","article-title":"An international consensus on the design of prospective clinical-translational trials in spatially fractionated radiation therapy for advanced gynecologic cancer","volume":"14","author":"Amendola","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B43","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1186\/s13643-024-02698-8","article-title":"Barriers and facilitators to enrollment in pediatric clinical trials: an overview of systematic reviews","volume":"13","author":"Bencheva","year":"2024","journal-title":"Syst Rev"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.28292","article-title":"Palliative radiation therapy for children with cancer","author":"Tsang","year":"2021","journal-title":"Pediatr Blood Cancer"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.21037\/apm.2019.05.01","article-title":"Palliative radiation oncology in pediatric patients","volume":"8","author":"Stachelek","year":"2019","journal-title":"Ann Palliat Med"},{"key":"B46","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.jpainsymman.2024.08.013","article-title":"Utilization of palliative radiation in pediatric oncology patients during the end-of-life (EOL)","volume":"68","author":"Cuviello","year":"2024","journal-title":"J Pain Symptom Manage"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.radonc.2019.05.017","article-title":"Clinical practice and outcomes of palliative radiation therapy in pediatric oncology patients: An international comparison of experiences from two distinct countries and health care systems","volume":"140","author":"Rao","year":"2019","journal-title":"Radiother Oncol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.417","article-title":"High-dose radiation as a dramatic, immunological primer in locally advanced melanoma","volume":"7","author":"Mohiuddin","year":"2015","journal-title":"Cureus"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.548132","article-title":"Combined high-dose LATTICE radiation therapy and immune checkpoint blockade for advanced bulky tumors: the concept and a case report","volume":"10","author":"Jiang","year":"2020","journal-title":"Front Oncol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1667\/RADE-20-00065.1","article-title":"Evidence for early stage anti-tumor immunity elicited by spatially fractionated radiotherapy-immunotherapy combinations","volume":"194","author":"Johnsrud","year":"2020","journal-title":"Radiat Res"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22147755","article-title":"Microbeam radiotherapy-A novel therapeutic approach to overcome radioresistance and enhance anti-tumour response in melanoma","volume":"22","author":"Trappetti","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B52","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.semradonc.2019.12.006","article-title":"Novel radiation therapy paradigms and immunomodulation: heresies and hope","volume":"30","author":"Dutt","year":"2020","journal-title":"Semin Radiat Oncol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"100691","DOI":"10.1016\/j.ctro.2023.100691","article-title":"Combining spatially fractionated radiation therapy (SFRT) and immunotherapy opens new rays of hope for enhancing therapeutic ratio","volume":"44","author":"Lu","year":"2024","journal-title":"Clin Transl Radiat Oncol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1007\/s11912-023-01473-7","article-title":"Immune priming with spatially fractionated radiation therapy","volume":"25","author":"Lukas","year":"2023","journal-title":"Curr Oncol Rep"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1648847\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:18:52Z","timestamp":1761542332000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1648847\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,27]]},"references-count":54,"alternative-id":["10.3389\/fonc.2025.1648847"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2025.1648847","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,27]]},"article-number":"1648847"}}